|
ERAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.924800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.763580E-02 |
| Normal-vs-Stage2 |
1.238560E-03 |
| Normal-vs-Stage3 |
4.641900E-03 |
| Normal-vs-Stage4 |
3.557900E-02 |
| Stage1-vs-Stage2 |
9.933900E-02 |
| Stage1-vs-Stage3 |
3.260600E-01 |
| Stage1-vs-Stage4 |
8.005600E-01 |
| Stage2-vs-Stage3 |
3.893800E-01 |
| Stage2-vs-Stage4 |
2.295400E-01 |
| Stage3-vs-Stage4 |
6.459000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.636600E-03 |
| Normal-vs-AfricanAmerican |
2.687000E-01 |
| Normal-vs-Asian |
4.760800E-01 |
| Caucasian-vs-AfricanAmerican |
4.052600E-01 |
| Caucasian-vs-Asian |
8.206500E-02 |
| AfricanAmerican-vs-Asian |
6.862800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.702400E-03 |
| Normal-vs-Female |
8.423500E-03 |
| Male-vs-Female |
4.611000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.734400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.323100E-03 |
| Normal-vs-Age(61-80Yrs) |
6.279300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.728400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.088000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.820000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.527400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.059000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.418600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.834600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.063000E-01 |
| Classical-VS-Follicular |
5.59970003699561E-09 |
| Classical-VS-Other |
2.508800E-01 |
| Classical-VS-Normal |
8.401700E-02 |
| Tall-VS-Follicular |
1.517700E-03 |
| Tall-VS-Other |
3.771200E-01 |
| Tall-VS-Normal |
1.929960E-01 |
| Follicular-VS-Other |
4.338600E-01 |
| Follicular-VS-Normal |
4.14340000087776E-08 |
| Other-VS-Normal |
9.121800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.475960E-03 |
| Normal-vs-N1 |
2.820800E-03 |
| N0-vs-N1 |
5.834600E-01 |
|
|
